UroGen Pharma Ltd

Company Snapshot
400 Alexander Park Drive
Princeton, NJ 08540
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 200
https://www.urogen.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$10,790,000
$42,885,000
$56,703,000
Operating Income
($126,739,000)
($92,292,000)
($79,041,000)
Net Income
($128,484,000)
($110,820,000)
($109,783,000)
2020
Gross Profit
$10,790,000
Operating Income
($126,739,000)
Net Income
($128,484,000)
2021
Gross Profit
$42,885,000
Operating Income
($92,292,000)
Net Income
($110,820,000)
2022
Gross Profit
$56,703,000
Operating Income
($79,041,000)
Net Income
($109,783,000)
The above data on UroGen Pharma Ltd came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Elizabeth Barrett
Director, President and Chief Executive Officer
$1,071,739
$753,195
$45,626
$1,870,560
Elizabeth Barrett
$1,870,560
Director, President and Chief Executive Officer
Jason Smith
General Counsel, Chief Compliance Officer and Corporate Secretary
$648,919
$208,539
$68,663
$926,121
Jason Smith
$926,121
General Counsel, Chief Compliance Officer and Corporate Secretary
Dong Kim
Vice President Finance
$502,303
$191,331
$44,382
$738,016
Dong Kim
$738,016
Vice President Finance
Arie Belldegrun
Chairman of the Board
$200,000
$58,499
$0
$258,499
Arie Belldegrun
$258,499
Chairman of the Board
Daniel Wildman
Director
$45,000
$197,830
$0
$242,830
Daniel Wildman
$242,830
Director
UroGen Pharma Ltd listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us